Since ALDOB is an enzyme involved in the glycolytic pathway, we investigated whether its higher expression would enhance aerobic glycolytic activity, specifically the ability to convert glucose to pyruvate (Glyco) and maximal glycolytic capacity (GC), in CRC cells, without any inhibitory effects (Fig. 2F). The gene discussed is ALDOB; the disease is colorectal carcinoma.